--- title: "Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation" type: "News" locale: "en" url: "https://longbridge.com/en/news/294056526.md" description: "Beta Bionics (NASDAQ:BBNX) maintains a comfortable cash position with US$200m in reserves and zero debt, providing a 3.3-year runway despite a US$61m annual burn. While cash burn increased by 2.9%, revenue surged 58%, indicating strong growth. The company's market cap of US$706m suggests it can easily raise additional capital if needed. Analysts remain unconcerned about the cash burn, viewing the spending as justified by robust top-line expansion." datetime: "2026-07-28T11:15:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294056526.md) - [en](https://longbridge.com/en/news/294056526.md) - [zh-HK](https://longbridge.com/zh-HK/news/294056526.md) generator: "portal-rs" --- # Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed. So should **Beta Bionics** (NASDAQ:BBNX) shareholders be worried about its cash burn? In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. ## Does Beta Bionics Have A Long Cash Runway? A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. When Beta Bionics last reported its March 2026 balance sheet in April 2026, it had zero debt and cash worth US$200m. Looking at the last year, the company burnt through US$61m. So it had a cash runway of about 3.3 years from March 2026. There's no doubt that this is a reassuringly long runway. The image below shows how its cash balance has been changing over the last few years. NasdaqGM:BBNX Debt to Equity History July 28th 2026 View our latest analysis for Beta Bionics ## How Well Is Beta Bionics Growing? Some investors might find it troubling that Beta Bionics is actually *increasing* its cash burn, which is up 2.9% in the last year. But looking on the bright side, its revenue gained by 58%, lending some credence to the growth narrative. The company needs to keep up that growth, if it is to really please shareholders. We think it is growing rather well, upon reflection. Clearly, however, the crucial factor is whether the company will grow its business going forward. For that reason, it makes a lot of sense to take a look at our analyst forecasts for the company. ## How Easily Can Beta Bionics Raise Cash? While Beta Bionics seems to be in a decent position, we reckon it is still worth thinking about how easily it could raise more cash, if that proved desirable. Generally speaking, a listed business can raise new cash through issuing shares or taking on debt. One of the main advantages held by publicly listed companies is that they can sell shares to investors to raise cash and fund growth. By looking at a company's cash burn relative to its market capitalisation, we gain insight on how much shareholders would be diluted if the company needed to raise enough cash to cover another year's cash burn. Beta Bionics has a market capitalisation of US$706m and burnt through US$61m last year, which is 8.7% of the company's market value. That's a low proportion, so we figure the company would be able to raise more cash to fund growth, with a little dilution, or even to simply borrow some money. ## So, Should We Worry About Beta Bionics' Cash Burn? It may already be apparent to you that we're relatively comfortable with the way Beta Bionics is burning through its cash. In particular, we think its revenue growth stands out as evidence that the company is well on top of its spending. While its increasing cash burn wasn't great, the other factors mentioned in this article more than make up for weakness on that measure. After taking into account the various metrics mentioned in this report, we're pretty comfortable with how the company is spending its cash, as it seems on track to meet its needs over the medium term. Its important for readers to be cognizant of the risks that can affect the company's operations, and we've picked out **2 warning signs for Beta Bionics** that investors should know when investing in the stock. Of course **Beta Bionics may not be the best stock to buy**. So you may wish to see this **free** collection of companies boasting high return on equity, or this list of stocks with high insider ownership. ### Valuation is complex, but we're here to simplify it. Discover if Beta Bionics might be undervalued or overvalued with our detailed analysis, featuring **fair value estimates, potential risks, dividends, insider trades, and its financial condition.** Access Free Analysis ### Related Stocks - [BBNX.US](https://longbridge.com/en/quote/BBNX.US.md) ## Related News & Research - [Have Beta Bionics Insiders Been Selling Stock?](https://longbridge.com/en/news/298111067.md) - [Beta Bionics (NASDAQ:BBNX) Insider Sells 4,221 Shares of Stock](https://longbridge.com/en/news/298030991.md) - [Beta Bionics CEO Sean Saint disposes of 5,641 common shares for $113,261.01](https://longbridge.com/en/news/298077212.md) - [BETA Technologies (NYSE:BETA) Shares Up 6% After Insider Buying Activity](https://longbridge.com/en/news/298052458.md) - [Major Insider Move Signals Rising Confidence in BETA Technologies](https://longbridge.com/en/news/297987673.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**